Middle East & Africa Sclerotherapy Market Size & Outlook
Middle East & Africa sclerotherapy market, 2016-2027 (US$M)
Related Markets
MEA sclerotherapy market highlights
- The MEA sclerotherapy market generated a revenue of USD 25.8 million in 2020.
- The market is expected to grow at a CAGR of 4.7% from 2021 to 2027.
- In terms of segment, detergents was the largest revenue generating agent in 2020.
- Detergents is the most lucrative agent segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2021 to 2027.
MEA data book summary
| Market revenue in 2020 | USD 25.8 million |
| Market revenue in 2027 | USD 35.6 million |
| Growth rate | 4.7% (CAGR from 2020 to 2027) |
| Largest segment | Detergents |
| Fastest growing segment | Detergents |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Detergents, Chemical Irritants, Osmotic Agents |
| Key market players worldwide | B2Gold Corp, LGM Pharma, Troikaa Pharmaceuticals, Mylan, Perrigo Co PLC, Merz Pharma, Medi-Globe |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.8% of the global sclerotherapy market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2027.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 320.1 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sclerotherapy Market Scope
Sclerotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa sclerotherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sclerotherapy market will help companies and investors design strategic landscapes.
Detergents was the largest segment with a revenue share of 42.25% in 2020. Horizon Databook has segmented the Middle East & Africa sclerotherapy market based on detergents, chemical irritants, osmotic agents covering the revenue growth of each sub-segment from 2016 to 2027.
High spending capacity resulting in high living standards, superior medical infrastructure, surging prevalence of obesity, high acceptance of technologically advanced treatment options and increasing adoption of less invasive treatment modalities in countries like United Arab Emirates and Kingdom of Saudi Arabia, are creating a demand for the Sclerotherapy market.
However, factors like availability of less number of skilled professionals, lack of medical infrastructure and lack of treatment awareness in country like Africa may lead to the low market share in the MEA region.
Reasons to subscribe to Middle East & Africa sclerotherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa sclerotherapy market databook
-
Our clientele includes a mix of sclerotherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa sclerotherapy market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa sclerotherapy market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
MEA sclerotherapy market size, by country, 2016-2027 (US$M)
Middle East & Africa Sclerotherapy Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
